The global hip and knee surgical implants market is anticipated to grow at a compound annual growth rate of 9.54 percent to 2022, according to Digital Journal.
Here are five key points:
1. The market is expected to reach $34.57 billion by 2022, up from $18.26 billion in 2015.
2. Technological advancements and a large geriatric population will spur market growth.
3. Poor reimbursements will hinder market growth.
4. Zimmer Biomet leads the market.
5. Other key players include B. Braun/Aesculap, ConforMIS, Corin, DJO Hip, Exactech, Johnson & Johnson, Mathys AG, Medacta, MicroPort Orthopedics, Smith & Nephew, Stryker, Think Surgical, Waldemar LINK and Wright Medical.